Yvonne J. Summers

Manchester, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 48 publications

Real-world Safety and Effectiveness of Neoadjuvant Chemoimmunotherapy in Squamous Cell Lung Cancer: A Retrospective European Multicenter Study.

Real-world Safety and Effectiveness of Neoadjuvant Chemoimmunotherapy in Squamous Cell Lung Cancer: A Retrospective European Multicenter Study.

Journal: Clinical lung cancer

Published: April 07, 2026

Evaluation of Biomarkers for Sacituzumab Govitecan in Metastatic Non-Small Cell Lung Cancer: Insights From the EVOKE-01 Study.

Evaluation of Biomarkers for Sacituzumab Govitecan in Metastatic Non-Small Cell Lung Cancer: Insights From the EVOKE-01 Study.

Journal: Cancer research communications

Published: January 22, 2026

Structured Expert Elicitation of Long-Term Survival in Non-small Cell Lung Cancer: A Case Study Applying Guidance from NICE Technical Support Document 26.

Structured Expert Elicitation of Long-Term Survival in Non-small Cell Lung Cancer: A Case Study Applying Guidance from NICE Technical Support Document 26.

Journal: Applied health economics and health policy

Published: December 08, 2025

Real-world comparative effectiveness of sotorasib versus docetaxel monotherapy in second line and beyond for advanced or metastatic non-small cell lung cancer: A national database analysis from England.

Real-world comparative effectiveness of sotorasib versus docetaxel monotherapy in second line and beyond for advanced or metastatic non-small cell lung cancer: A national database analysis from England.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: November 06, 2025

Evolutionary characterization of lung cancer metastasis.

Evolutionary characterization of lung cancer metastasis.

Journal: Nature

Published: June 29, 2025

Consolidation thoracic radiotherapy after chemoimmunotherapy in ES-SCLC: A multicentric retrospective analysis.

Consolidation thoracic radiotherapy after chemoimmunotherapy in ES-SCLC: A multicentric retrospective analysis.

Journal: European journal of cancer (Oxford, England : 1990)

Published: May 08, 2025

Correlation between irAEs and survival outcomes in patients with ES-SCLC treated with first-line chemoimmunotherapy.

Correlation between irAEs and survival outcomes in patients with ES-SCLC treated with first-line chemoimmunotherapy.

Journal: European journal of cancer (Oxford, England : 1990)

Published: February 25, 2025

First-line osimertinib compared to earlier generation TKIs in advanced EGFR-mutant NSCLC: A real-world survival analysis.

First-line osimertinib compared to earlier generation TKIs in advanced EGFR-mutant NSCLC: A real-world survival analysis.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: November 05, 2024

A phase II trial of mTORC1/2 inhibition in STK11 deficient non small cell lung cancer.

A phase II trial of mTORC1/2 inhibition in STK11 deficient non small cell lung cancer.

Journal: NPJ precision oncology

Published: July 30, 2024

Author Correction: The evolution of lung cancer and impact of subclonal selection in TRACERx.

Author Correction: The evolution of lung cancer and impact of subclonal selection in TRACERx.

Journal: Nature

Published: July 04, 2024

Service Evaluation of MyChristie-MyHealth, an Electronic Patient-Reported Outcome Measure Integrated Into Clinical Cancer Care.

Service Evaluation of MyChristie-MyHealth, an Electronic Patient-Reported Outcome Measure Integrated Into Clinical Cancer Care.

Journal: JCO clinical cancer informatics

Published: April 04, 2024

Extended pleurectomy decortication and chemotherapy versus chemotherapy alone for pleural mesothelioma (MARS 2): a phase 3 randomised controlled trial.

Extended pleurectomy decortication and chemotherapy versus chemotherapy alone for pleural mesothelioma (MARS 2): a phase 3 randomised controlled trial.

Journal: The Lancet. Respiratory medicine

Published: November 17, 2023

Showing 1-12 of 48

Last Updated: 09/26/2026